Alok Raghav is an Research Scientist at Multidisciplinary Research Unit, Ganesh Shankar Vidyarthi Medical College, Kanpur, India. He has completed his PhD and postdoctorate research on albumin protein glycation in diabetes and its associated complications and has extensive research experience in the field of medical science and healthcare. His research focuses on designing new targets against glycosylation using nanotechnology approach to treat human diseases. He has published more than 40 research papers in international peer reviewed journals and has presented his work at various reputed national and International conferences. He is also a recipient of the prestigious Endocrine Society Award, USA and honorary fellow of Indian Association of Nanoscience and Nanotechnology. He is serving as reviewer and editorial board member of several international journals.